CollPlant Biotechnologies Ltd.
CLGN
$0.42
$0.013.38%
NASDAQ
| 12/31/2024 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | 10.36% | 10.36% | -2.76% | ||
| Total Depreciation and Amortization | -5.10% | -5.10% | -2.30% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -24.52% | -24.52% | -23.37% | ||
| Change in Net Operating Assets | -218.18% | -218.18% | 126.06% | ||
| Cash from Operations | -0.46% | -0.46% | 12.22% | ||
| Capital Expenditure | 57.86% | 57.86% | 30.69% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | 100.00% | ||
| Cash from Investing | 58.57% | 58.57% | 45.95% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -- | -- | -- | ||
| Foreign Exchange rate Adjustments | 53.85% | 53.85% | 133.05% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 2.45% | 2.45% | 17.56% | ||